Last news
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Notified -...

iHerb Reaches 29-Year Milestone with Global Anniversary Sale

iHerb Reaches 29-Year Milestone with Global Anniversary Sale

Notified -...

AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025

AAVantgarde to Present Updated Clinical Data from LUCE-1 Study at EURetina 2025

Notified -...

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Ascom and AvaSure partner in AI-powered virtual nursing solutions for North America

Notified -...

Bitget COO Vugar Usi Zade Speaks on Future of Web3 at Economic Times World Leaders Forum

Bitget COO Vugar Usi Zade Speaks on Future of Web3 at Economic Times World Leaders Forum

Notified -...

Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research

Countdown For A Cure Awards $350,000 Grant to Minovia Therapeutics to Advance Groundbreaking Mitochondrial Biomarker Research

Notified -...

VCI Global Partners with Reveillon Group to Launch Global RWA Lounge Network and Creator Monetization Platform

VCI Global Partners with Reveillon Group to Launch Global RWA Lounge Network and Creator Monetization Platform

Notified -...

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Notified -...

1 ... 224 225 226 227 228 229 230 231 232 ... 1106
menu
menu